Health
Novel antiviral drug candidate blocks SARS-CoV-2 reproduction in cells – Drug Target Review
In human cell assays, a drug candidate called PF-00835231 has demonstrated success at blocking the reproduction of SARS-CoV-2.

Posted: 16 September 2020 | Victoria Rees (Drug Target Review) | No comments yet
In human cells, a drug candidate called PF-00835231 has demonstrated success at blocking the reproduction of SARS-CoV-2.
A study in human cells found that an antiviral drug candidate called PF-00835231 may be at least as potent as the drug remdesivir at blocking the reproduction of SARS-CoV-2, which causes COVID-19.
PF-00835231 was shown in preliminary research in cells – conducted by New York University Grossman…
-
General19 hours ago
Young boy flown to Brisbane hospital after K’gari dingo attack
-
General16 hours ago
British and US planes fly 12-hour mission to patrol Russian border
-
Noosa News20 hours ago
Warm weather could make way for rain with ‘damaging winds, large hail’
-
General4 hours ago
Byford rail extension opening marks final stage of Perth Metronet